Comparison Overview

Celesio AG

VS

Novo Nordisk

Celesio AG

Stockholmer Platz 1, Stuttgart, 70180
Last Update: 2026-04-04
View Profile
Between 800 and 849
http://www.mckesson.eu

On 12 September 2017, Celesio AG has officially announced its renaming to McKesson Europe AG, based on the shareholders’ decision at the Annual General Meeting 2017. Documents of Celesio AG remain documents of McKesson Europe AG. More information can be found in the press release"Renaming: Celesio AG becomes McKesson Europe AG"​: http://www.mckesson.eu/mck-en/news-press/releases-mckessoneurope/renaming--celesio-ag-becomes-mckesson-europe-ag/29600 Please refer to our new company site: http://www.linkedin.com/company/mckesson-europe Imprint: McKesson Europe AG Stockholmer Platz 1 70173 Stuttgart (Germany) Telephone: +49 711 5001-00 Telefax: +49 711 5001-1260 [email protected] http://www.facebook.com/mckessoneurope http://twitter.com/mckessoneurope

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 100
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Novo Nordisk

Novo Alle, Bagsværd, DK, 2880
Last Update: 2026-04-01
Between 800 and 849
https://www.novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 65,152
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/celesio-ag.jpeg
Celesio AG
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/novo-nordisk.jpeg
Novo Nordisk
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Celesio AG
100%
Compliance Rate
0/4 Standards Verified
Novo Nordisk
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Celesio AG in 2026.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Novo Nordisk in 2026.

Incident History — Celesio AG (X = Date, Y = Severity)

Celesio AG cyber incidents detection timeline including parent company and subsidiaries

Incident History — Novo Nordisk (X = Date, Y = Severity)

Novo Nordisk cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/celesio-ag.jpeg
Celesio AG
Incidents

No Incident

https://images.rankiteo.com/companyimages/novo-nordisk.jpeg
Novo Nordisk
Incidents

No Incident

FAQ

Novo Nordisk company demonstrates a stronger AI Cybersecurity Score compared to Celesio AG company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Novo Nordisk company has disclosed a higher number of cyber incidents compared to Celesio AG company.

In the current year, Novo Nordisk company and Celesio AG company have not reported any cyber incidents.

Neither Novo Nordisk company nor Celesio AG company has reported experiencing a ransomware attack publicly.

Neither Novo Nordisk company nor Celesio AG company has reported experiencing a data breach publicly.

Neither Novo Nordisk company nor Celesio AG company has reported experiencing targeted cyberattacks publicly.

Neither Celesio AG company nor Novo Nordisk company has reported experiencing or disclosing vulnerabilities publicly.

Neither Celesio AG nor Novo Nordisk holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Celesio AG company nor Novo Nordisk company has publicly disclosed detailed information about the number of their subsidiaries.

Novo Nordisk company employs more people globally than Celesio AG company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Celesio AG nor Novo Nordisk holds SOC 2 Type 1 certification.

Neither Celesio AG nor Novo Nordisk holds SOC 2 Type 2 certification.

Neither Celesio AG nor Novo Nordisk holds ISO 27001 certification.

Neither Celesio AG nor Novo Nordisk holds PCI DSS certification.

Neither Celesio AG nor Novo Nordisk holds HIPAA certification.

Neither Celesio AG nor Novo Nordisk holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

nimiq/core-rs-albatross is a Rust implementation of the Nimiq Proof-of-Stake protocol based on the Albatross consensus algorithm. Prior to version 1.3.0, two peer-facing consensus request handlers assume that the history index is always available and call blockchain.history_store.history_index().unwrap() directly. That assumption is false by construction. HistoryStoreProxy::history_index() explicitly returns None for the valid HistoryStoreProxy::WithoutIndex state. when a full node is syncing or otherwise running without the history index, a remote peer can send RequestTransactionsProof or RequestTransactionReceiptsByAddress and trigger an Option::unwrap() panic on the request path. This issue has been patched in version 1.3.0.

Published
Date
2026-04-03
Updated
Date
2026-04-03
Risk Information
cvss3
Base: 5.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L
References
Description

PraisonAI is a multi-agent teams system. Prior to version 1.5.95, FileTools.download_file() in praisonaiagents validates the destination path but performs no validation on the url parameter, passing it directly to httpx.stream() with follow_redirects=True. An attacker who controls the URL can reach any host accessible from the server including cloud metadata services and internal network services. This issue has been patched in version 1.5.95.

Published
Date
2026-04-03
Updated
Date
2026-04-03
Risk Information
cvss3
Base: 8.6
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N
References
Description

PraisonAI is a multi-agent teams system. Prior to version 4.5.97, OAuthManager.validate_token() returns True for any token not found in its internal store, which is empty by default. Any HTTP request to the MCP server with an arbitrary Bearer token is treated as authenticated, granting full access to all registered tools and agent capabilities. This issue has been patched in version 4.5.97.

Published
Date
2026-04-03
Updated
Date
2026-04-03
Risk Information
cvss3
Base: 9.1
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
References
Description

PraisonAI is a multi-agent teams system. Prior to version 4.5.97, the PraisonAI Gateway server accepts WebSocket connections at /ws and serves agent topology at /info with no authentication. Any network client can connect, enumerate registered agents, and send arbitrary messages to agents and their tool sets. This issue has been patched in version 4.5.97.

Published
Date
2026-04-03
Updated
Date
2026-04-03
Risk Information
cvss3
Base: 9.1
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
References
Description

PraisonAI is a multi-agent teams system. Prior to version 4.5.90, MCPToolIndex.search_tools() compiles a caller-supplied string directly as a Python regular expression with no validation, sanitization, or timeout. A crafted regex causes catastrophic backtracking in the re engine, blocking the Python thread for hundreds of seconds and causing a complete service outage. This issue has been patched in version 4.5.90.

Published
Date
2026-04-03
Updated
Date
2026-04-03
Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
References